KBLB · Kraig Biocraft Laboratories, Inc.
What's happening
- KBLB is up 0.25% today, trading at $0.08. — Live quote
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Valuation Measures & Ratios
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 10-Q, filed 2026-08-13; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -208.5%. Finnhub fundamentals ↗
- Trailing 52-week price return is -8.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on KBLB
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Operating income | -$703.4K | -$825.5K | -$1.4M | -$637.7K | -$580.5K | -$423.8K | -$1.5M | -$448.7K |
| Net income | -$909.5K | -$942.7K | -$1.5M | -$726.1K | -$600.0K | -$433.2K | -$1.6M | -$507.9K |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $4.3M | $3.7M | $2.6M | $2.4M | $1.6M | $1.3M | $1.5M | $2.0M |
| Total liabilities | $11.0M | $10.8M | $10.6M | $10.3M | $10.1M | $9.9M | $9.7M | $9.4M |
| Stockholders' equity | -$6.8M | -$7.1M | -$8.0M | -$8.0M | -$8.5M | -$8.5M | -$8.1M | -$7.4M |
| Total current assets | $3.6M | $3.0M | $1.9M | $1.6M | $839.0K | $452.7K | $740.3K | $1.2M |
| Total current liabilities | $10.9M | $10.7M | $10.4M | $10.2M | $10.0M | $9.8M | $9.6M | $9.3M |
| Cash & equivalents | $3.4M | $2.9M | $1.8M | $1.6M | $785.5K | $397.0K | $673.3K | $1.2M |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Inventory | $134.1K | $74.3K | $29.1K | $29.1K | $6.9K | $6.9K | $6.9K | $6.9K |
| Property, plant & equipment | $54.4K | $32.9K | $25.0K | $31.0K | $37.0K | $39.0K | $44.7K | $46.5K |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | — | — | — | — | — | — | — | — |
| Retained earnings | -$58.6M | -$57.7M | -$56.7M | -$55.9M | -$54.4M | -$53.7M | -$53.1M | -$52.2M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$598.7K | -$529.7K | -$449.5K | -$461.9K | -$443.1K | -$434.5K | -$512.5K | -$326.3K |
| Investing cash flow | -$28.6K | -$14.1K | $71.8K | $222.8K | $143.5K | — | -$4.2K | — |
| Financing cash flow | $1.1M | $1.6M | $602.2K | $1.0M | $688.1K | $158.2K | $0 | -$5.2K |
| Free cash flow | -$627.3K | -$543.8K | -$451.1K | -$461.9K | -$446.9K | — | -$516.8K | — |
| Capital expenditures | $28.6K | $14.1K | $1.6K | $0 | $3.8K | — | $4.2K | — |
| Share-based compensation | — | — | — | — | — | — | — | — |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in inventory | $59.8K | $45.2K | $0 | $22.2K | — | — | — | — |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | -$3.4M | -$3.1M | -$2.6M | -$2.1M | -$2.8M |
| Net income | -$3.6M | -$3.4M | -$3.0M | -$3.8M | -$8.0M |
| EPS (diluted) | $0.00 | $0.00 | $0.00 | $0.00 | — |
| EPS (basic) | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.6M | $1.5M | $3.2M | $4.6M | $3.0M |
| Total liabilities | $10.6M | $9.7M | $8.9M | $8.1M | $8.3M |
| Stockholders' equity | -$8.0M | -$8.1M | -$5.7M | -$3.5M | -$5.3M |
| Total current assets | $1.9M | $740.3K | $2.6M | $4.0M | $2.4M |
| Total current liabilities | $10.4M | $9.6M | $8.9M | $8.1M | $8.2M |
| Cash & equivalents | $1.8M | $673.3K | $2.6M | $3.9M | — |
| Accounts receivable | — | — | — | — | — |
| Inventory | $29.1K | $6.9K | $6.9K | $6.6K | — |
| Property, plant & equipment | $25.0K | $44.7K | $66.6K | $87.9K | $110.9K |
| Accrued liabilities | — | — | — | $107.9K | — |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | — | — | — | — | — |
| Retained earnings | -$56.7M | -$53.1M | -$49.7M | -$46.7M | -$42.8M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$1.8M | -$1.8M | -$1.2M | -$1.9M | -$1.8M |
| Investing cash flow | $438.0K | -$4.2K | -$6.4K | -$5.0K | -$547.4K |
| Financing cash flow | $2.5M | -$35.2K | -$60.0K | $3.4M | $3.9M |
| Free cash flow | -$1.8M | -$1.8M | -$1.3M | -$1.9M | -$1.9M |
| Capital expenditures | $5.4K | $4.2K | $6.4K | $5.0K | $97.2K |
| Share-based compensation | — | — | — | — | — |
| Change in accounts receivable | — | — | — | — | — |
| Change in inventory | $22.2K | — | $304 | $6.6K | — |
| Change in accounts payable | — | — | — | — | — |
| Purchases of investments | — | — | — | — | $450.2K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding KBLB as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2022-05-17 to 2025-05-27
Recent transactions
- Most recent: Rice Jonathan Richard (Chief Operating Officer) — In-the-money option exercise of 314,636 shares on 2025-05-27.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Rice Jonathan Richard | Chief Operating Officer | In-the-money option exercise | 2025-05-27 | 314,636 |
| Thompson Kimberly Kraig | Chief Executive Officer | Acquired/disposed by will or inheritance | 2025-03-31 | 27,500 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2025-05-27 | Rice Jonathan Richard | Chief Operating Officer | In-the-money option exercise | 314,636 | $0.08 |
| 2025-03-31 | Thompson Kimberly Kraig | Chief Executive Officer | Acquired/disposed by will or inheritance | 27,500 | $0.09 |
| 2025-03-31 | Thompson Kimberly Kraig | Chief Executive Officer | Acquired/disposed by will or inheritance | 62,500 | $0.09 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 06:15 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-13 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-05-14 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-03-30 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-02-18 | 8-K | 2026-02-18 | View on SEC.gov → |
| 2025-11-12 | 10-Q | 2025-09-30 | View on SEC.gov → |
| 2025-08-14 | 10-Q | 2025-06-30 | View on SEC.gov → |
| 2025-05-29 | 4 | 2025-05-27 | View on SEC.gov → |
| 2025-05-15 | 10-Q | 2025-03-31 | View on SEC.gov → |
| 2025-04-10 | 4 | 2025-03-31 | View on SEC.gov → |
| 2025-04-08 | 4 | 2025-03-31 | View on SEC.gov → |
| 2025-03-28 | 10-K | 2024-12-31 | View on SEC.gov → |
| 2025-03-24 | 4 | 2024-12-04 | View on SEC.gov → |
Recent news
Headlines about KBLB (Kraig Biocraft Laboratories, Inc.). Links open the publisher — we don’t host full articles.
-
Kraig Biocraft Laboratories, Inc. (KBLB) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
Kraig Biocraft Laboratories to Present Spider Silk Commercialization Strategy at International Silk Congress
Yahoo · 2026-10-19 -
Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets
Yahoo · 2026-10-19 -
Kraig Biocraft Laboratories Seeks Production Expansion as Spider Silk Output Reaches New Records
Yahoo · 2026-10-12 -
Kraig Biocraft files for expanded investment licence
Seeking Alpha · 2026-10-12 -
Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth
Yahoo · 2026-10-12 -
Indistinguishable From Magic: How Kraig Labs Brought Spider Silk into Reality
Yahoo Finance · 2026-10-06 -
Kraig Biocraft Laboratories Ramps Spider Silk Production Across Three Centers as Commercial Deliveries Begin
Yahoo Finance · 2026-10-05
No headlines in this category right now — try “All”.